RING
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98157840
- Registration number
- 7708106
- Mark type
- Stylized text
- Filed
- 30 Aug 2023
- Published for opposition
- 02 Jan 2024
- Registered
- 25 Feb 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy
Owner
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 31 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Oct 2024 — USE AMENDMENT FILED
- 04 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 27 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Aug 2024 — SOU EXTENSION 1 GRANTED
- 27 Aug 2024 — SOU EXTENSION 1 FILED
- 27 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jan 2024 — PUBLISHED FOR OPPOSITION